Development of dementia in type 2 diabetes patients: mechanisms of insulin resistance and antidiabetic drug development

HIGHLIGHTS

  • who: Desh Deepak Singh et al. from the Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India have published the article: Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development, in the Journal: Cells 2021, 10, x FOR PEER REVIEW of 17/Oct/2022

SUMMARY

    Iations. Type-2 diabetes_mellitus (T2DM) is the most common type of metabolic disorder caused by abnormal regulation of insulin. Non-alcoholic fatty liver disease is involved in the development of vascular and nonvascular dementia. More than 18 million people are living . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?